These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 1452137

  • 21. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V, Beyne P, Frommherz K, Roullet JB, Drüeke T.
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [Abstract] [Full Text] [Related]

  • 22. [Effects of high-carbohydrate diet on VLDL-, HDL-, and apolipoprotein CII-receptor activities on liver parenchymal and non-parenchymal cells in rats].
    Zhang L, Liu B.
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Jun; 24(2):131-4. PubMed ID: 8244288
    [Abstract] [Full Text] [Related]

  • 23. Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.
    Wakabayashi Y, Okubo M, Shimada H, Sato N, Koide A, Marumo F, Nakamura H.
    Metabolism; 1987 Sep; 36(9):815-20. PubMed ID: 3626863
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K, Gartside PS, Hynd BA, Kashyap ML.
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [Abstract] [Full Text] [Related]

  • 25. [Plasma HDL subfractions in endogenous hypertriglyceridemia].
    Xu M, Liu B, Fan P.
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):12-5. PubMed ID: 12205910
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 28. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.
    Reyes-Soffer G, Sztalryd C, Horenstein RB, Holleran S, Matveyenko A, Thomas T, Nandakumar R, Ngai C, Karmally W, Ginsberg HN, Ramakrishnan R, Pollin TI.
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):63-72. PubMed ID: 30580564
    [Abstract] [Full Text] [Related]

  • 29. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG, Patsch W, Kuisk I, Gonen B, Schonfeld G.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [Abstract] [Full Text] [Related]

  • 30. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED, Le NA, Li X, Martinson D, Brown WV.
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [Abstract] [Full Text] [Related]

  • 31. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ, Campos H, Moye LA, Sacks FM.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):853-8. PubMed ID: 12637336
    [Abstract] [Full Text] [Related]

  • 32. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.
    Kidney Int; 2000 Sep 01; 58(3):1238-46. PubMed ID: 10972686
    [Abstract] [Full Text] [Related]

  • 33. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM, Nichols AV, Krauss RM, Norum RA.
    J Clin Invest; 1984 Nov 01; 74(5):1601-13. PubMed ID: 6501564
    [Abstract] [Full Text] [Related]

  • 34. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects.
    Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Allen C, Hogg E, Glueck CJ, Jackson RL.
    Am J Clin Nutr; 1983 Feb 01; 37(2):233-43. PubMed ID: 6823885
    [Abstract] [Full Text] [Related]

  • 35. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ, Breckenridge WC.
    Biochim Biophys Acta; 1996 Oct 18; 1303(3):222-32. PubMed ID: 8908157
    [Abstract] [Full Text] [Related]

  • 36. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S, Homma Y, Sakane H, Kobayashi T, Ozawa H, Okajima Y.
    Tokai J Exp Clin Med; 1996 Dec 18; 21(4-6):165-9. PubMed ID: 9300976
    [Abstract] [Full Text] [Related]

  • 37. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
    Liu BW, Hynd BA, Kashyap ML.
    Biochem Biophys Res Commun; 1984 Jun 29; 121(3):946-52. PubMed ID: 6588972
    [Abstract] [Full Text] [Related]

  • 38. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE.
    Biochemistry; 2008 Sep 30; 47(39):10491-502. PubMed ID: 18767813
    [Abstract] [Full Text] [Related]

  • 39. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML, Srivastava LS, Chen CY, Perisutti CG, Campbell M, Lutmer RF, Glueck CJ.
    J Clin Invest; 1977 Jul 30; 60(1):171-80. PubMed ID: 194919
    [Abstract] [Full Text] [Related]

  • 40. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo.
    Liu BW, Jiang Y, Fu MD, Liu Y, Fan P.
    Mol Cell Biochem; 2000 Apr 30; 207(1-2):131-5. PubMed ID: 10888238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.